ICA Foundation                     LNG IUS                     Projects                     Application

About us

Press release

Our impact

Project Resources



Photo: Population Council

The International Contraceptive Access (ICA) Foundation
was established in December 2003 and is a collaboration between the Bayer Healthcare Pharmaceuticals, a world-wide leading specialty pharmaceutical company, and Population Council, an international nonprofit nongovernmental organization.

The objective of the Foundation is to provide local service-delivery organizations with the levonorgestrel releasing intrauterine system (LNG IUS) contraceptive devices on a not-for-profit basis and ultimately serve the reproductive needs of women in resource-poor settings, primarily in developing countries.

By September 2016, the ICA Foundation has donated 84.410 LNG IUS to organizations in 29 countries. Country projects include collaborations with local not-for-profit organizations, hospitals, and global partners with a network of service delivery facilities in developing countries. Donation recipients work through a variety of means to provide women access to contraceptive options and quality family planning services.

As the Foundation’s focus is service delivery, product donations for research purposes are not accepted.


         Board of Trustees         Contact         Disclaimer         Sitemap